Pipeline
Our product pipeline forms the anchors of our franchises in transplant medicine and gastroenterology. The following chart describes the status of our product candidates:
* Vancocin® is approved for oral administration for treatment of antibiotic-associated pseudomembranous colitis caused by Clostridium difficile and enterocolitis caused by Staphylococcus aureus, including methicillin-resistant strains. For prescribing information, please download the package insert (PDF).
**Cinryze™ (C1 Esterase Inhibitor [human]) is indicated for routine prophylaxis against angioedema attacks in adolescent and adult patients with Hereditary Angioedema (HAE).
***Maribavir is currently under internal review.